THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $876 | +682.1% | 52,615 | +384.7% | 0.00% | +100.0% |
| Q2 2023 | $112 | -5.1% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $118 | -3.3% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $122 | -99.9% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $110,000 | +12.2% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $98,000 | -5.8% | 10,856 | 0.0% | 0.00% | – |
| Q1 2022 | $104,000 | -13.3% | 10,856 | 0.0% | 0.00% | – |
| Q4 2021 | $120,000 | +50.0% | 10,856 | 0.0% | 0.00% | – |
| Q3 2021 | $80,000 | -49.4% | 10,856 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $158,000 | -28.8% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $222,000 | +15.0% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $193,000 | +19.9% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $161,000 | -29.4% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $228,000 | -9.2% | 10,856 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $251,000 | -10.7% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $281,000 | +33.2% | 10,856 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $211,000 | +19.2% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $177,000 | -28.0% | 10,856 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $246,000 | -11.5% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $278,000 | -21.7% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $355,000 | +44.3% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $246,000 | -6.5% | 10,856 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $263,000 | -15.7% | 10,856 | -2.9% | 0.00% | 0.0% |
| Q4 2017 | $312,000 | -18.5% | 11,175 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $383,000 | -18.0% | 11,175 | -4.7% | 0.00% | 0.0% |
| Q2 2017 | $467,000 | +8.1% | 11,728 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $432,000 | +11.9% | 11,728 | -3.1% | 0.00% | 0.0% |
| Q4 2016 | $386,000 | -12.1% | 12,100 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $439,000 | +59.6% | 12,100 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $275,000 | +5.4% | 12,100 | -12.7% | 0.00% | 0.0% |
| Q1 2016 | $261,000 | -4.4% | 13,864 | -16.7% | 0.00% | 0.0% |
| Q4 2015 | $273,000 | +49.2% | 16,641 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $183,000 | -24.7% | 16,641 | -10.7% | 0.00% | 0.0% |
| Q2 2015 | $243,000 | -24.8% | 18,635 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $323,000 | +11.0% | 18,635 | -4.4% | 0.00% | +50.0% |
| Q4 2014 | $291,000 | +114.0% | 19,502 | +231.3% | 0.00% | +100.0% |
| Q3 2014 | $136,000 | -27.7% | 5,887 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $188,000 | – | 5,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |